Facebook Stock Hits New Low After Wedbush Note

FB stock is headed toward its worst quarter in six years

by Karee Venema

Published on Dec 24, 2018 at 10:03 AM

The shares of Facebook, Inc. (NASDAQ:FB) are trading down 1.4% at $123.212 -- earlier hitting a nearly two-year low of $123.05, after Wedbush removed the FAANG stock from its "Best Ideas" list. However, the brokerage firm maintained its "outperform" rating and $220 price target, a 76% premium to Friday's close.

Today's negative price action is just more of the same for FB stock, which is pacing for a 24% fourth-quarter loss -- its worst quarterly performance since the third-quarter of 2012. What's more, Facebook is on track to close below its 50-month moving average for the first time since the trendline formed in June 2016.

Against this backdrop, skepticism has been ramping up both in and outside of the options pits. In addition to a handful of FB stock downgrades, put buying has accelerated at the major options exchanges in recent weeks.

Drilling down on specific options, the January 2019 140 and 150 strikes are home to peak put open interest, with more than 97,000 contracts currently outstanding. Data shows at least some buy-to-open activity at each strike, suggesting options traders are targeting more losses for Facebook at the start of 2019.


a schaeffer's exclusive

5 NEW STOCK PICKS

We're celebrating 38 years with this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


What's Next for the American Wealth Gap
Porter Stansberry is predicting a major change in the American economic system.
S&P 500's Newest Member Hits Fresh Highs
CDW will be replacing Total System Services on the S&P 500 next week
VTVT Stock Eyes Fresh High on Upbeat Diabetes Drug Data
vTv Therapeutics just presented upbeat data for its mid-stage diabetes treatment
What's Next for the American Wealth Gap
Porter Stansberry is predicting a major change in the American economic system.